Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 5/20 | 0.43 |
| ▸ | MAOA | P21397 | 2/20 | 0.43 |
| ▸ | ADORA1 | P30542 | 10/20 | 0.41 |
| ▸ | ADORA2A | P29274 | 10/20 | 0.41 |
| ▸ | ALOX5AP | P20292 | 2/20 | 0.40 |
| ▸ | FEN1 | P39748 | 2/20 | 0.40 |
| ▸ | ATR | Q13535 | 1/20 | 0.35 |
| ▸ | IKBKB | O14920 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4113347 | 0.92 | MAOB (0.45) | MAOBMAOAADORA1ADORA2AALOX5AP | |
| SCHEMBL4775383 | 0.88 | MAOB (0.38) | MAOBMAOAADORA1ADORA2AALOX5AP | |
| SCHEMBL4101040 | 0.85 | ADORA2A (0.44) | MAOBMAOAADORA1ADORA2A | |
| SCHEMBL4110202 | 0.85 | ADORA1 (0.51) | ADORA1ADORA2AATR | |
| SCHEMBL4107496 | 0.78 | DCPS (0.48) | MAOBADORA2A | |
| SCHEMBL4096455 | 0.77 | MAOB (0.49) | MAOBMAOAADORA1ADORA2A | |
| SCHEMBL4108022 | 0.76 | MAOB (0.44) | MAOBMAOAALOX5APFEN1 | |
| SCHEMBL4107477 | 0.75 | ADORA2A (0.49) | ADORA1ADORA2AATR | |
| SCHEMBL4102014 | 0.74 | MAOB (0.44) | MAOBMAOAADORA1ADORA2AALOX5AP | |
| SCHEMBL4097472 | 0.74 | ADORA2A (0.53) | ADORA1ADORA2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008009076-A2 | SUBSTITUTED PYRIDO(3,2-D)PYRIMIDINES AND PHARMACEUTICAL COMPOSITIONS FOR TREATING VIRAL INFECTIONS | GILEAD SCIENCES, INC. (US) | 2008-01-24 | — | — | WO | claimed |